Global Gene Deletion Vaccine Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Gene Deletion Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Gene Deletion Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Single Gene Deletion Vaccine
  • 1.2.3 Double Gene Deletion Vaccine
• 1.3 Market by Application
  • 1.3.1 Global Gene Deletion Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Animal Health Center
  • 1.3.3 Veterinary Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Gene Deletion Vaccine Sales Estimates and Forecasts 2018-2029
• 2.2 Global Gene Deletion Vaccine Revenue by Region
  • 2.2.1 Global Gene Deletion Vaccine Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Gene Deletion Vaccine Revenue by Region (2018-2023)
  • 2.2.3 Global Gene Deletion Vaccine Revenue by Region (2024-2029)
  • 2.2.4 Global Gene Deletion Vaccine Revenue Market Share by Region (2018-2029)
• 2.3 Global Gene Deletion Vaccine Sales Estimates and Forecasts 2018-2029
• 2.4 Global Gene Deletion Vaccine Sales by Region
  • 2.4.1 Global Gene Deletion Vaccine Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Gene Deletion Vaccine Sales by Region (2018-2023)
  • 2.4.3 Global Gene Deletion Vaccine Sales by Region (2024-2029)
  • 2.4.4 Global Gene Deletion Vaccine Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Gene Deletion Vaccine Sales by Manufacturers
  • 3.1.1 Global Gene Deletion Vaccine Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Gene Deletion Vaccine Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gene Deletion Vaccine in 2022
• 3.2 Global Gene Deletion Vaccine Revenue by Manufacturers
  • 3.2.1 Global Gene Deletion Vaccine Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Gene Deletion Vaccine Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Gene Deletion Vaccine Revenue in 2022
• 3.3 Global Key Players of Gene Deletion Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Gene Deletion Vaccine Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Gene Deletion Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Gene Deletion Vaccine, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Gene Deletion Vaccine, Product Offered and Application
• 3.8 Global Key Manufacturers of Gene Deletion Vaccine, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Gene Deletion Vaccine Sales by Type
  • 4.1.1 Global Gene Deletion Vaccine Historical Sales by Type (2018-2023)
  • 4.1.2 Global Gene Deletion Vaccine Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• 4.2 Global Gene Deletion Vaccine Revenue by Type
  • 4.2.1 Global Gene Deletion Vaccine Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Gene Deletion Vaccine Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• 4.3 Global Gene Deletion Vaccine Price by Type
  • 4.3.1 Global Gene Deletion Vaccine Price by Type (2018-2023)
  • 4.3.2 Global Gene Deletion Vaccine Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Gene Deletion Vaccine Sales by Application
  • 5.1.1 Global Gene Deletion Vaccine Historical Sales by Application (2018-2023)
  • 5.1.2 Global Gene Deletion Vaccine Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• 5.2 Global Gene Deletion Vaccine Revenue by Application
  • 5.2.1 Global Gene Deletion Vaccine Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Gene Deletion Vaccine Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• 5.3 Global Gene Deletion Vaccine Price by Application
  • 5.3.1 Global Gene Deletion Vaccine Price by Application (2018-2023)
  • 5.3.2 Global Gene Deletion Vaccine Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Gene Deletion Vaccine Market Size by Type
  • 6.1.1 US & Canada Gene Deletion Vaccine Sales by Type (2018-2029)
  • 6.1.2 US & Canada Gene Deletion Vaccine Revenue by Type (2018-2029)
• 6.2 US & Canada Gene Deletion Vaccine Market Size by Application
  • 6.2.1 US & Canada Gene Deletion Vaccine Sales by Application (2018-2029)
  • 6.2.2 US & Canada Gene Deletion Vaccine Revenue by Application (2018-2029)
• 6.3 US & Canada Gene Deletion Vaccine Market Size by Country
  • 6.3.1 US & Canada Gene Deletion Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Gene Deletion Vaccine Sales by Country (2018-2029)
  • 6.3.3 US & Canada Gene Deletion Vaccine Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Gene Deletion Vaccine Market Size by Type
  • 7.1.1 Europe Gene Deletion Vaccine Sales by Type (2018-2029)
  • 7.1.2 Europe Gene Deletion Vaccine Revenue by Type (2018-2029)
• 7.2 Europe Gene Deletion Vaccine Market Size by Application
  • 7.2.1 Europe Gene Deletion Vaccine Sales by Application (2018-2029)
  • 7.2.2 Europe Gene Deletion Vaccine Revenue by Application (2018-2029)
• 7.3 Europe Gene Deletion Vaccine Market Size by Country
  • 7.3.1 Europe Gene Deletion Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Gene Deletion Vaccine Sales by Country (2018-2029)
  • 7.3.3 Europe Gene Deletion Vaccine Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Gene Deletion Vaccine Market Size
  • 8.1.1 China Gene Deletion Vaccine Sales (2018-2029)
  • 8.1.2 China Gene Deletion Vaccine Revenue (2018-2029)
• 8.2 China Gene Deletion Vaccine Market Size by Application
  • 8.2.1 China Gene Deletion Vaccine Sales by Application (2018-2029)
  • 8.2.2 China Gene Deletion Vaccine Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Gene Deletion Vaccine Market Size by Type
  • 9.1.1 Asia Gene Deletion Vaccine Sales by Type (2018-2029)
  • 9.1.2 Asia Gene Deletion Vaccine Revenue by Type (2018-2029)
• 9.2 Asia Gene Deletion Vaccine Market Size by Application
  • 9.2.1 Asia Gene Deletion Vaccine Sales by Application (2018-2029)
  • 9.2.2 Asia Gene Deletion Vaccine Revenue by Application (2018-2029)
• 9.3 Asia Gene Deletion Vaccine Sales by Region
  • 9.3.1 Asia Gene Deletion Vaccine Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Gene Deletion Vaccine Revenue by Region (2018-2029)
  • 9.3.3 Asia Gene Deletion Vaccine Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Gene Deletion Vaccine Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Gene Deletion Vaccine Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Virbac SA
  • 11.1.1 Virbac SA Company Information
  • 11.1.2 Virbac SA Overview
  • 11.1.3 Virbac SA Gene Deletion Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Virbac SA Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Virbac SA Recent Developments
• 11.2 Merck Animal Health
  • 11.2.1 Merck Animal Health Company Information
  • 11.2.2 Merck Animal Health Overview
  • 11.2.3 Merck Animal Health Gene Deletion Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Merck Animal Health Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Merck Animal Health Recent Developments
• 11.3 Zoetis Inc
  • 11.3.1 Zoetis Inc Company Information
  • 11.3.2 Zoetis Inc Overview
  • 11.3.3 Zoetis Inc Gene Deletion Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Zoetis Inc Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Zoetis Inc Recent Developments
• 11.4 Boehringer Ingelheim GmbH
  • 11.4.1 Boehringer Ingelheim GmbH Company Information
  • 11.4.2 Boehringer Ingelheim GmbH Overview
  • 11.4.3 Boehringer Ingelheim GmbH Gene Deletion Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 Boehringer Ingelheim GmbH Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Boehringer Ingelheim GmbH Recent Developments
• 11.5 Indian Immunologicals Ltd
  • 11.5.1 Indian Immunologicals Ltd Company Information
  • 11.5.2 Indian Immunologicals Ltd Overview
  • 11.5.3 Indian Immunologicals Ltd Gene Deletion Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Indian Immunologicals Ltd Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Indian Immunologicals Ltd Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Gene Deletion Vaccine Industry Chain Analysis
• 12.2 Gene Deletion Vaccine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Gene Deletion Vaccine Production Mode & Process
• 12.4 Gene Deletion Vaccine Sales and Marketing
  • 12.4.1 Gene Deletion Vaccine Sales Channels
  • 12.4.2 Gene Deletion Vaccine Distributors
• 12.5 Gene Deletion Vaccine Customers

13 Market Dynamics

• 13.1 Gene Deletion Vaccine Industry Trends
• 13.2 Gene Deletion Vaccine Market Drivers
• 13.3 Gene Deletion Vaccine Market Challenges
• 13.4 Gene Deletion Vaccine Market Restraints

14 Key Findings in The Global Gene Deletion Vaccine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Gene Deletion Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Single Gene Deletion Vaccine
• Table 3. Major Manufacturers of Double Gene Deletion Vaccine
• Table 4. Global Gene Deletion Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Gene Deletion Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 6. Global Gene Deletion Vaccine Revenue by Region (2018-2023) & (US$ Million)
• Table 7. Global Gene Deletion Vaccine Revenue by Region (2024-2029) & (US$ Million)
• Table 8. Global Gene Deletion Vaccine Revenue Market Share by Region (2018-2023)
• Table 9. Global Gene Deletion Vaccine Revenue Market Share by Region (2024-2029)
• Table 10. Global Gene Deletion Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global Gene Deletion Vaccine Sales by Region (2018-2023) & (K Units)
• Table 12. Global Gene Deletion Vaccine Sales by Region (2024-2029) & (K Units)
• Table 13. Global Gene Deletion Vaccine Sales Market Share by Region (2018-2023)
• Table 14. Global Gene Deletion Vaccine Sales Market Share by Region (2024-2029)
• Table 15. Global Gene Deletion Vaccine Sales by Manufacturers (2018-2023) & (K Units)
• Table 16. Global Gene Deletion Vaccine Sales Share by Manufacturers (2018-2023)
• Table 17. Global Gene Deletion Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 18. Global Gene Deletion Vaccine Revenue Share by Manufacturers (2018-2023)
• Table 19. Global Key Players of Gene Deletion Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
• Table 20. Gene Deletion Vaccine Price by Manufacturers 2018-2023 (USD/Unit)
• Table 21. Global Gene Deletion Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Gene Deletion Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Deletion Vaccine as of 2022)
• Table 23. Global Key Manufacturers of Gene Deletion Vaccine, Manufacturing Base Distribution and Headquarters
• Table 24. Global Key Manufacturers of Gene Deletion Vaccine, Product Offered and Application
• Table 25. Global Key Manufacturers of Gene Deletion Vaccine, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Gene Deletion Vaccine Sales by Type (2018-2023) & (K Units)
• Table 28. Global Gene Deletion Vaccine Sales by Type (2024-2029) & (K Units)
• Table 29. Global Gene Deletion Vaccine Sales Share by Type (2018-2023)
• Table 30. Global Gene Deletion Vaccine Sales Share by Type (2024-2029)
• Table 31. Global Gene Deletion Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 32. Global Gene Deletion Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 33. Global Gene Deletion Vaccine Revenue Share by Type (2018-2023)
• Table 34. Global Gene Deletion Vaccine Revenue Share by Type (2024-2029)
• Table 35. Gene Deletion Vaccine Price by Type (2018-2023) & (USD/Unit)
• Table 36. Global Gene Deletion Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
• Table 37. Global Gene Deletion Vaccine Sales by Application (2018-2023) & (K Units)
• Table 38. Global Gene Deletion Vaccine Sales by Application (2024-2029) & (K Units)
• Table 39. Global Gene Deletion Vaccine Sales Share by Application (2018-2023)
• Table 40. Global Gene Deletion Vaccine Sales Share by Application (2024-2029)
• Table 41. Global Gene Deletion Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 42. Global Gene Deletion Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 43. Global Gene Deletion Vaccine Revenue Share by Application (2018-2023)
• Table 44. Global Gene Deletion Vaccine Revenue Share by Application (2024-2029)
• Table 45. Gene Deletion Vaccine Price by Application (2018-2023) & (USD/Unit)
• Table 46. Global Gene Deletion Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
• Table 47. US & Canada Gene Deletion Vaccine Sales by Type (2018-2023) & (K Units)
• Table 48. US & Canada Gene Deletion Vaccine Sales by Type (2024-2029) & (K Units)
• Table 49. US & Canada Gene Deletion Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 50. US & Canada Gene Deletion Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 51. US & Canada Gene Deletion Vaccine Sales by Application (2018-2023) & (K Units)
• Table 52. US & Canada Gene Deletion Vaccine Sales by Application (2024-2029) & (K Units)
• Table 53. US & Canada Gene Deletion Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 54. US & Canada Gene Deletion Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 55. US & Canada Gene Deletion Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 56. US & Canada Gene Deletion Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 57. US & Canada Gene Deletion Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 58. US & Canada Gene Deletion Vaccine Sales by Country (2018-2023) & (K Units)
• Table 59. US & Canada Gene Deletion Vaccine Sales by Country (2024-2029) & (K Units)
• Table 60. Europe Gene Deletion Vaccine Sales by Type (2018-2023) & (K Units)
• Table 61. Europe Gene Deletion Vaccine Sales by Type (2024-2029) & (K Units)
• Table 62. Europe Gene Deletion Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 63. Europe Gene Deletion Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 64. Europe Gene Deletion Vaccine Sales by Application (2018-2023) & (K Units)
• Table 65. Europe Gene Deletion Vaccine Sales by Application (2024-2029) & (K Units)
• Table 66. Europe Gene Deletion Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 67. Europe Gene Deletion Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 68. Europe Gene Deletion Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 69. Europe Gene Deletion Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 70. Europe Gene Deletion Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 71. Europe Gene Deletion Vaccine Sales by Country (2018-2023) & (K Units)
• Table 72. Europe Gene Deletion Vaccine Sales by Country (2024-2029) & (K Units)
• Table 73. China Gene Deletion Vaccine Sales by Type (2018-2023) & (K Units)
• Table 74. China Gene Deletion Vaccine Sales by Type (2024-2029) & (K Units)
• Table 75. China Gene Deletion Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 76. China Gene Deletion Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 77. China Gene Deletion Vaccine Sales by Application (2018-2023) & (K Units)
• Table 78. China Gene Deletion Vaccine Sales by Application (2024-2029) & (K Units)
• Table 79. China Gene Deletion Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 80. China Gene Deletion Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 81. Asia Gene Deletion Vaccine Sales by Type (2018-2023) & (K Units)
• Table 82. Asia Gene Deletion Vaccine Sales by Type (2024-2029) & (K Units)
• Table 83. Asia Gene Deletion Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 84. Asia Gene Deletion Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 85. Asia Gene Deletion Vaccine Sales by Application (2018-2023) & (K Units)
• Table 86. Asia Gene Deletion Vaccine Sales by Application (2024-2029) & (K Units)
• Table 87. Asia Gene Deletion Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 88. Asia Gene Deletion Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 89. Asia Gene Deletion Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 90. Asia Gene Deletion Vaccine Revenue by Region (2018-2023) & (US$ Million)
• Table 91. Asia Gene Deletion Vaccine Revenue by Region (2024-2029) & (US$ Million)
• Table 92. Asia Gene Deletion Vaccine Sales by Region (2018-2023) & (K Units)
• Table 93. Asia Gene Deletion Vaccine Sales by Region (2024-2029) & (K Units)
• Table 94. Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Type (2018-2023) & (K Units)
• Table 95. Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Type (2024-2029) & (K Units)
• Table 96. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 97. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Application (2018-2023) & (K Units)
• Table 99. Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Application (2024-2029) & (K Units)
• Table 100. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 101. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 103. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Country (2018-2023) & (K Units)
• Table 106. Middle East, Africa and Latin America Gene Deletion Vaccine Sales by Country (2024-2029) & (K Units)
• Table 107. Virbac SA Company Information
• Table 108. Virbac SA Description and Major Businesses
• Table 109. Virbac SA Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
• Table 110. Virbac SA Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Virbac SA Recent Developments
• Table 112. Merck Animal Health Company Information
• Table 113. Merck Animal Health Description and Major Businesses
• Table 114. Merck Animal Health Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
• Table 115. Merck Animal Health Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Merck Animal Health Recent Developments
• Table 117. Zoetis Inc Company Information
• Table 118. Zoetis Inc Description and Major Businesses
• Table 119. Zoetis Inc Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
• Table 120. Zoetis Inc Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Zoetis Inc Recent Developments
• Table 122. Boehringer Ingelheim GmbH Company Information
• Table 123. Boehringer Ingelheim GmbH Description and Major Businesses
• Table 124. Boehringer Ingelheim GmbH Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
• Table 125. Boehringer Ingelheim GmbH Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Boehringer Ingelheim GmbH Recent Developments
• Table 127. Indian Immunologicals Ltd Company Information
• Table 128. Indian Immunologicals Ltd Description and Major Businesses
• Table 129. Indian Immunologicals Ltd Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
• Table 130. Indian Immunologicals Ltd Gene Deletion Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Indian Immunologicals Ltd Recent Developments
• Table 132. Key Raw Materials Lists
• Table 133. Raw Materials Key Suppliers Lists
• Table 134. Gene Deletion Vaccine Distributors List
• Table 135. Gene Deletion Vaccine Customers List
• Table 136. Gene Deletion Vaccine Market Trends
• Table 137. Gene Deletion Vaccine Market Drivers
• Table 138. Gene Deletion Vaccine Market Challenges
• Table 139. Gene Deletion Vaccine Market Restraints
• Table 140. Research Programs/Design for This Report
• Table 141. Key Data Information from Secondary Sources
• Table 142. Key Data Information from Primary Sources

List of Figures

• Figure 1. Gene Deletion Vaccine Product Picture
• Figure 2. Global Gene Deletion Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Gene Deletion Vaccine Market Share by Type in 2022 & 2029
• Figure 4. Single Gene Deletion Vaccine Product Picture
• Figure 5. Double Gene Deletion Vaccine Product Picture
• Figure 6. Global Gene Deletion Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Gene Deletion Vaccine Market Share by Application in 2022 & 2029
• Figure 8. Animal Health Center
• Figure 9. Veterinary Clinic
• Figure 10. Others
• Figure 11. Gene Deletion Vaccine Report Years Considered
• Figure 12. Global Gene Deletion Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 13. Global Gene Deletion Vaccine Revenue 2018-2029 (US$ Million)
• Figure 14. Global Gene Deletion Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 15. Global Gene Deletion Vaccine Revenue Market Share by Region (2018-2029)
• Figure 16. Global Gene Deletion Vaccine Sales 2018-2029 ((K Units)
• Figure 17. Global Gene Deletion Vaccine Sales Market Share by Region (2018-2029)
• Figure 18. US & Canada Gene Deletion Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 19. US & Canada Gene Deletion Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 20. Europe Gene Deletion Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 21. Europe Gene Deletion Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 22. China Gene Deletion Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 23. China Gene Deletion Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. Asia (excluding China) Gene Deletion Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 25. Asia (excluding China) Gene Deletion Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. Middle East, Africa and Latin America Gene Deletion Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 27. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. The Gene Deletion Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 29. The Top 5 and 10 Largest Manufacturers of Gene Deletion Vaccine in the World: Market Share by Gene Deletion Vaccine Revenue in 2022
• Figure 30. Global Gene Deletion Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 31. Global Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• Figure 32. Global Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• Figure 33. Global Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• Figure 34. Global Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• Figure 35. US & Canada Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• Figure 36. US & Canada Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• Figure 37. US & Canada Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• Figure 38. US & Canada Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• Figure 39. US & Canada Gene Deletion Vaccine Revenue Share by Country (2018-2029)
• Figure 40. US & Canada Gene Deletion Vaccine Sales Share by Country (2018-2029)
• Figure 41. U.S. Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 42. Canada Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 43. Europe Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• Figure 44. Europe Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• Figure 45. Europe Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• Figure 46. Europe Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• Figure 47. Europe Gene Deletion Vaccine Revenue Share by Country (2018-2029)
• Figure 48. Europe Gene Deletion Vaccine Sales Share by Country (2018-2029)
• Figure 49. Germany Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 50. France Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 51. U.K. Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 52. Italy Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 53. Russia Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 54. China Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• Figure 55. China Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• Figure 56. China Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• Figure 57. China Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• Figure 58. Asia Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• Figure 59. Asia Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• Figure 60. Asia Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• Figure 61. Asia Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• Figure 62. Asia Gene Deletion Vaccine Revenue Share by Region (2018-2029)
• Figure 63. Asia Gene Deletion Vaccine Sales Share by Region (2018-2029)
• Figure 64. Japan Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 65. South Korea Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 66. China Taiwan Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 67. Southeast Asia Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 68. India Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 69. Middle East, Africa and Latin America Gene Deletion Vaccine Sales Market Share by Type (2018-2029)
• Figure 70. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue Market Share by Type (2018-2029)
• Figure 71. Middle East, Africa and Latin America Gene Deletion Vaccine Sales Market Share by Application (2018-2029)
• Figure 72. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue Market Share by Application (2018-2029)
• Figure 73. Middle East, Africa and Latin America Gene Deletion Vaccine Revenue Share by Country (2018-2029)
• Figure 74. Middle East, Africa and Latin America Gene Deletion Vaccine Sales Share by Country (2018-2029)
• Figure 75. Brazil Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 76. Mexico Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 77. Turkey Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 78. Israel Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 79. GCC Countries Gene Deletion Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 80. Gene Deletion Vaccine Value Chain
• Figure 81. Gene Deletion Vaccine Production Process
• Figure 82. Channels of Distribution
• Figure 83. Distributors Profiles
• Figure 84. Bottom-up and Top-down Approaches for This Report
• Figure 85. Data Triangulation
• Figure 86. Key Executives Interviewed